Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Franccesco Boeno"'
Publikováno v:
Physiology. 38
Doxorubicin (DOX) is a first-line chemotherapeutic agent used to treat a wide range of malignancies including breast and lymphatic cancers. However, the clinical use of DOX is limited due to off-target toxicity to healthy organs. DOX-induced nephroto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b4ca06a82341a07b9c400bdba7a2c2b
https://doi.org/10.1152/physiol.2023.38.s1.5732553
https://doi.org/10.1152/physiol.2023.38.s1.5732553
Publikováno v:
Physiology. 38
BACKGROUND: Sepsis is a condition of life-threatening organ dysfunction caused by a dysregulated host response to infection and carries a high risk of mortality. A rapidly growing number of “sepsis survivors” experience persistent and severe skel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9420c89733a8ff1eb185e74bfc47e30f
https://doi.org/10.1152/physiol.2023.38.s1.5792235
https://doi.org/10.1152/physiol.2023.38.s1.5792235
Autor:
Vivian Doerr, Ryan Montalvo, Cesar Jacintho Moritz, Franccesco Boeno, Imtiaz Dowllah, Ashley Smuder
Publikováno v:
Physiology. 38
Doxorubicin (DOX) is a highly effective chemotherapeutic used in cancer treatment. However, its use is associated with the development of cardiac dysfunction, which can negatively affect patient outcomes and reduce overall survival. While no clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71df36e8d3d7dfa00b22143a95095f9a
https://doi.org/10.1152/physiol.2023.38.s1.5796072
https://doi.org/10.1152/physiol.2023.38.s1.5796072
Publikováno v:
Drug Week; 6/16/2023, p3137-3137, 1p
Publikováno v:
Drug Week; 6/16/2023, p278-278, 1p
Publikováno v:
Women's Health Weekly; 6/16/2023, p1412-1412, 1p